Gilead Sciences Inc (GILD)

69.50
-0.06(-0.09%)
After Hours
69.30
-0.20(-0.29%)
- Real-time Data
  • Volume:
    6,551,537
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    69.43 - 70.79

GILD Overview

Prev. Close
69.56
Day's Range
69.43-70.79
Revenue
27.48B
Open
69.49
52 wk Range
56.56-73.34
EPS
5.84
Volume
6,551,537
Market Cap
87.18B
Dividend (Yield)
2.84
(4.09%)
Average Volume (3m)
6,809,432
P/E Ratio
11.91
Beta
0.35
1-Year Change
12.9%
Shares Outstanding
1,254,383,522
Next Earnings Date
08 Feb 2022
What is your sentiment on Gilead Sciences Inc?
or
Market is currently closed. Voting is open during market hours.

Gilead Sciences Inc Company Profile

Employees
13600

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy
  • Good job GILD. bullish move forward
    0
    • Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
      0
      • Up Again
        0
        • Time to load up before the big rise coming next week
          3
          • Classic pump n’ dump. What a shambles
            1
            • Will reach above 95
              5
              • Good time to accumulate.
                1
                • Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
                  2
                  • High chance to be trading above 90, good long stock
                    4
                    • By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
                      3
                      • Gilead has ebola medical called remdesivir, currently seems to be successfull also in treating covid, final study should be available end of March
                        1
                        • not if they dont find a vaccine. it will be condidered a waste of time and money and the stock will drop.
                          4
                          • gild and regn is working out on covid19 vaccine. both price getting higher as they promise to work it out. they will boom once they found the vaccine
                            0
                            • buy position lets go profit by jordan
                              0
                              Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                              Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.